← Leaderboards
Michelle M Williams
Vanderbilt University
$909,422
Attributed
$909,422
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2015–25$250K$187.5K$125K$62.5K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$909,422 · 4
By mechanism
R00$481,955 · 1
K99$228,684 · 1
F32$141,968 · 1
F31$56,815 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Raymond Nelson Dubois$22,706,669
- Nancy Joan Brown$32,445,188
- William M Grady$22,313,396
- Talat Alp Ikizler$13,998,196
- Timothy S Blackwell$28,109,454
Others in their field
Top investigators on “Malignant Breast Neoplasm”
- David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
- Norman Wolmark · Nsabp Foundation, Inc.$122,067,540
- Walter John Curran · Thomas Jefferson University$97,002,422
- Monica M Bertagnolli · Strang Cancer Prevention Center$84,975,759
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$68,847,428
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$60,763,376
Research focus
Malignant Breast NeoplasmResponseSmall Hairpin RnaCellsNeoplastic CellPathway InteractionsTumorTriple-Negative Invasive Breast CarcinomaBreast Cancer CellResistanceMetastatic Neoplasm To The LungMediatingAnti-Tumor Immune ResponseBilirubinBreast Cancer MetastasisMetastatic Breast CancerMortalityImmunotherapyCell PhysiologyImmunosuppressionIn VivoCessation Of LifeHeme Oxygenase-1Heme
Grant awards (8)
Targeting heme metabolism to initiate an immune response against breast cancer liver metastasis$232,955
R00 · FY2025 · CA · contact PI
Targeting heme metabolism to initiate an immune response against breast cancer liver metastasis$249,000
R00 · FY2024 · CA · contact PI
Targeting heme metabolism to initiate an immune response against breast cancer liver metastasis$114,342
K99 · FY2023 · CA · contact PI
Targeting heme metabolism to initiate an immune response against breast cancer liver metastasis$114,342
K99 · FY2022 · CA · contact PI
Impact of heme catabolism on triple negative breast cancer metastasis via immune-suppression$73,958
F32 · FY2021 · CA · contact PI
Impact of heme catabolism on triple negative breast cancer metastasis via immune-suppression$68,010
F32 · FY2020 · CA · contact PI
Mcl-1 drives resistance of luminal breast cancers to targeted therapies$26,702
F31 · FY2016 · CA · contact PI
Mcl-1 drives resistance of luminal breast cancers to targeted therapies$30,113
F31 · FY2015 · CA · contact PI